Gingivitis, Heart Transplant, Periodontitis, Systemic Inflammation
Conditions
Keywords
Non-Surgical Periodontal Therapy, High-Sensitivity C-Reactive Protein, hs-CRP, Heart Transplant Recipients, Periodontal Disease
Brief summary
Heart transplant recipients frequently exhibit chronic low-grade systemic inflammation, which can contribute to allograft dysfunction and cardiovascular complications. Periodontitis, a chronic inflammatory disease of the tooth-supporting tissues, is a modifiable but often overlooked source of this inflammatory burden. This prospective study evaluated whether non-surgical periodontal therapy (NSPT) - comprising full-mouth debridement and oral hygiene instruction - could reduce systemic inflammatory markers in clinically stable heart transplant recipients. Adults who had undergone heart transplantation at least one year earlier and presented with gingivitis or periodontitis underwent a comprehensive periodontal examination and blood sampling for high-sensitivity C-reactive protein (hs-CRP), leukocyte count, hematocrit, and platelet count. Participants then received NSPT, with periodontal and hematological parameters reassessed three months later. Findings from this study may clarify whether periodontal therapy represents a useful adjunctive strategy for reducing systemic inflammatory burden in this medically complex population.
Detailed description
This prospective interventional study evaluated the effect of non-surgical periodontal therapy (NSPT) on clinical periodontal parameters and systemic inflammatory markers in clinically stable heart transplant recipients. It was conducted as a follow-on to a previously published cross-sectional study by the same group, which demonstrated elevated hs-CRP levels in heart transplant recipients with periodontitis compared with periodontally healthy recipients and those with gingivitis. Eligible participants were heart transplant recipients at least one year post-transplantation, clinically stable, and diagnosed with gingivitis or periodontitis requiring NSPT. Participants were excluded if they had received systemic antibiotics within the preceding six months, had undergone periodontal treatment within the previous year, or presented with systemic inflammatory or infectious conditions that could independently confound inflammatory marker levels (e.g., uncontrolled diabetes mellitus, active infection requiring antibiotic therapy). At baseline, a calibrated periodontist performed a comprehensive periodontal examination using a UNC-15 periodontal probe, recording plaque index (PI), bleeding on probing (BOP), probing depth (PD), and clinical attachment level (CAL). Periodontal diagnoses were assigned according to the current classification of periodontal and peri-implant diseases and conditions. Fasting venous blood samples were collected for measurement of serum hs-CRP, leukocyte count, hematocrit, and platelet count. All participants subsequently received NSPT, consisting of full-mouth debridement with ultrasonic instrumentation and hand curettes, together with professional oral hygiene instruction. Periodontal and hematological parameters were reassessed three months after completion of therapy. Of 33 heart transplant recipients initially assessed for eligibility, 30 met inclusion criteria, 20 consented to participate and underwent NSPT, and 17 completed the 3-month follow-up and were included in the final analysis. Statistical analyses were performed using Python (SciPy, pandas). Normality of within-patient difference scores was assessed with the Shapiro-Wilk test; paired-samples t-tests (Cohen's d) were applied where differences were approximately normally distributed, and Wilcoxon signed-rank tests (effect size r) were used otherwise. Between-group delta comparisons employed independent-samples t-tests or Mann-Whitney U tests. Statistical significance was set at p \< 0.05 (two-tailed).
Interventions
Ultrasonic instrumentation and hand curettes used to remove supra- and subgingival plaque and calculus deposits.
Sponsors
Study design
Intervention model description
All participants received non-surgical periodontal therapy; periodontal and systemic inflammatory parameters were compared at baseline and 3 months post-therapy within the same group.
Eligibility
Inclusion criteria
* Clinically stable heart transplant recipient At least one year post-transplantation Diagnosed with gingivitis or periodontitis requiring non-surgical periodontal therapy (NSPT) No systemic antibiotic use within the preceding six months No periodontal treatment within the previous year
Exclusion criteria
* Systemic inflammatory or infectious conditions that could independently affect inflammatory marker levels Uncontrolled diabetes mellitus Recent active infection requiring antibiotic therapy Periodontally healthy status (no gingivitis or periodontitis)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in serum high-sensitivity C-reactive protein (hs-CRP) | Baseline and 3 months post-NSPT | Serum hs-CRP levels measured at baseline and 3 months following non-surgical periodontal therapy (NSPT), compared within the same group of heart transplant recipients. Unit of Measure: mg/L |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Plaque Index (PI) | Baseline and 3 months post-NSPT | Assessed on tooth surfaces using the Silness-Löe Plaque Index, scored via visual and tactile examination. Unit of Measure: score 0-3 for based on the amount of plaque |
| Change in Bleeding on Probing (BOP | Baseline and 3 months post-NSPT | Measured using a UNC-15 periodontal probe after periodontal pocket measurement . Unit of Measure: percentage of sites positive for bleeding |
| Change in Clinical Attachment Level (CAL) | Baseline and 3 months post-NSPT | Measured using a UNC-15 periodontal probe, before and after NSPT. Unit of Measure: millimeters |
| Change in Probing Depth (PD) | Baseline and 3 months post-NSPT | Measured using a UNC-15 periodontal probe, before and after NSPT. Unit of Measure: millimeters |
| Change in Leukocyte Count | Baseline and 3 months post-NSPT | Measured using an automated hematology analyzer, before and after NSPT. Unit of Measure: ×10³/µL |
| Change in Hematocrit | Baseline and 3 months post-NSPT | Measured using an automated hematology analyzer, before and after NSPT. Unit of Measure: percentage (%) |
| Change in Platelet Count | Baseline and 3 months post-NSPT | Measured using an automated hematology analyzer, before and after NSPT. Unit of Measure: ×10³/µL |